Search
Showing results for "1"
News & Events
Getting the most out of the CGM schemeIf your child/adolescent has been approved to use CGM but decides they do not want to use it, it is important to complete a NDSS change/termination form, which needs to be returned to your clinic team.
Research
Anaesthesia, pain and recovery profiles in children following dental extractionsThe aim of this prospective cohort study was to describe the anaesthetic practices, rates of postoperative pain and the recovery trajectory of children having urgent dental extractions at our institution.
Research
Gender Balance in Anesthesiology: Is a Change of Societal Mindset Needed?With great interest, we are following the discussion on Speaker Gender Representation and Trends in Authorship. While it is indeed very popular and important to look at speaker representation, authorship, or board membership by gender, the underlying reasons for the unequal gender representation are not as easy to determine. Counting numbers on panels or boards may also not add up to real representation.
Research
An observational study of the reactogenicity and immunogenicity of 13-valent pneumococcal conjugate vaccine in women of childbearing age in Papua New GuineaMaternal immunization with pneumococcal conjugate vaccine (PCV) may protect young infants in high-risk settings against the high risk of pneumococcal infections in early life. The aim of this study was to determine the safety and immunogenicity of 13-valent PCV (PCV13) in healthy women of childbearing age in PNG.
Research
Acute Flaccid Paralysis in Australian Children from 2007 to 2017Acute flaccid paralysis (AFP) surveillance continues globally as part of the World Health Organization's goal to eradicate poliomyelitis. The Australian Paediatric Surveillance Unit, Paediatric Active Enhanced Disease Surveillance network, and National Enterovirus Reference Laboratory collaborate in AFP surveillance in Australia, capturing and reviewing cases of AFP for all aetiologies in order to exclude poliovirus. We aimed to describe the AFP epidemiology in childhood over an 11 year period.
Research
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trialBRAF genomic alterations are the most common oncogenic drivers in pediatric low-grade glioma.
Discover the impact of our achievements in the "real world".
News & Events
Celebrating 35 years of impact at The Kids Research Institute AustraliaCoinciding with the Institute’s 35th year of research to improve the health and wellbeing of children and families, the 2025 Impact Report celebrates research which has been translated into policy or practice, and which has led to a paradigm shift in the way we respond to childhood health and wellbeing.
As WA's first research collaboration dedicated to mental health, we work across The Kids Research Institute Australia and beyond to do the research that the community wants to see happen.
News & Events
Embrace research presented at SMHR conferenceAssociate Professor Bep Uink and Head of Kulunga Aboriginal Unit Cheryl Bridge watched on by Associate Professor Yael Perry at the SMHR conference.